Gertraud Orend
Strasbourg, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Targeting the extracellular matrix with Tenascin-C-specific CAR T cells extends survival in preclinical models of glioblastoma.
Journal: Journal for immunotherapy of cancer
Published: October 13, 2025
Tenascin-C orchestrates radiotherapy-induced head and neck tumor regression.
Journal: EMBO molecular medicine
Published: April 02, 2025
Targeting the MAtrix REgulating MOtif abolishes several hallmarks of cancer, triggering antitumor immunity.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 09, 2024
Granzyme B cleaves tenascin-C to release its C-terminal domain in rheumatoid arthritis.
Journal: JCI insight
Published: April 11, 2024
Tenascin-C targeting strategies in cancer.
Journal: Matrix biology : journal of the International Society for Matrix Biology
Published: December 20, 2023
Investigating Chemokine-Matrix Networks in Breast Cancer: Tenascin-C Sets the Tone for CCL2.
Journal: International journal of molecular sciences
Published: March 31, 2023
Advances on the roles of tenascin-C in cancer.
Journal: Journal of cell science
Published: September 14, 2022
Infiltrating CD8+ T cells and M2 macrophages are retained in tumor matrix tracks enriched in low tension fibronectin fibers.
Journal: Matrix biology : journal of the International Society for Matrix Biology
Published: May 11, 2022
Dicer1 deficient mice exhibit premature aging and metabolic perturbations in adipocytes.
Journal: iScience
Published: February 03, 2022
Editorial: Tenascins - Key Players in Tissue Homeostasis and Defense.
Journal: Frontiers in immunology
Published: December 13, 2021
Modulating tenascin-C functions by targeting the MAtrix REgulating MOtif, "MAREMO".
Journal: Matrix biology : journal of the International Society for Matrix Biology
Published: August 31, 2021
Last Updated: 09/26/2026